Gina B. Scott

905 citations

27 papers · 684 indexed · h-index 14

Co-authors: Stephen A. Rose H.C. Ardley Philip A. Robinson Alexander F. Markham Christopher Parrish Gordon Cook Stephen G. Oliver Alan Melcher
Topics: Virus-based gene therapy research (7 papers)CAR-T cell therapy research (7 papers)Immune Cell Function and Interaction (6 papers)
Cited by: Oncology Immunology Hematology
Journals: Journal of Biological Chemistry Blood PLoS ONE
Partner nations: United Kingdom United States Italy

In The Last Decade

Gina B. Scott

27 papers receiving 676 citations

Peers

Countries citing papers authored by Gina B. Scott

Since Specialization

Citations

This map shows the geographic impact of Gina B. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gina B. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gina B. Scott more than expected).

Fields of papers citing papers by Gina B. Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gina B. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gina B. Scott. The network helps show where Gina B. Scott may publish in the future.

Co-authorship network of co-authors of Gina B. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Gina B. Scott. A scholar is included among the top collaborators of Gina B. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gina B. Scott. Gina B. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cells 2023 ·Molecular Therapy — Oncolytics ·Matthew Holmes,Gina B. Scott,(unknown),(unknown),(unknown),(unknown),Victoria A. Jennings,Christy Ralph,Cathy Burton,Alan Melcher,Peter Hillmen,Christopher Parrish,Fiona Errington‐Mais	4
2	Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche 2021 ·Journal for ImmunoTherapy of Cancer ·(unknown),G Migneco,Gina B. Scott,Jenny Down,(unknown),(unknown),Victoria A. Jennings,Babatunde O. Oyajobi,Karen J. Scott,Emma J. West,Christy Ralph,Adel Samson,Elizabeth J. Ilett,Munitta Muthana,Matt Coffey,Alan Melcher,Christopher Parrish,Gordon Cook,Michelle A. Lawson,Fiona Errington‐Mais	14
3	Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition 2019 ·Molecular Therapy ·Victoria A. Jennings,Gina B. Scott,(unknown),Karen J. Scott,G Migneco,Brian A. Keller,(unknown),Oliver Donnelly,Howard Peach,Donald Dewar,Kevin J. Harrington,Hardev Pandha,Adel Samson,Richard G. Vile,Alan Melcher,Fiona Errington‐Mais	47
4	Downregulation of myeloma-induced ICOS-L and regulatory T cell generation by lenalidomide and dexamethasone therapy 2015 ·Cellular Immunology ·Gina B. Scott,(unknown),Christopher Parrish,Philip Wood,Gordon Cook	22
5	Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia 2015 ·Leukemia ·Christopher Parrish,Gina B. Scott,G Migneco,Karen J. Scott,Lynette P. Steele,Elizabeth J. Ilett,Emma J. West,Kathryn Hall,Peter J. Selby,David L. Buchanan,Abraham Varghese,Mark S. Cragg,Matt Coffey,Peter Hillmen,Alan Melcher,Fiona Errington‐Mais	32
6	Epithelial cell ADAM17 activation by Helicobacter pylori: role of ADAM17 C-terminus and Threonine-735 phosphorylation 2014 ·Microbes and Infection ·Urszula L. McClurg,Kazuma Danjo,(unknown),Gina B. Scott,Philip A. Robinson,Jean E. Crabtree	13
7	Th17 Cells Are Increased in the Bone Marrow but Not the Peripheral Blood in Multiple Myeloma and Demonstrate Defective Functionality and Aberrant Phenotypes 2014 ·Blood ·Christopher Parrish,Gina B. Scott,Graham P. Cook,Gordon Cook,(unknown),(unknown)	1
8	Combination Therapy with Reovirus and Immunomodulatory Drugs Induces Direct Oncolytic and Immune-Mediated Killing of Multiple Myeloma Cells and Overcomes Stromal-Mediated Microenvironmental Protection 2014 ·Blood ·Christopher Parrish,Gina B. Scott,Matt Coffey,Alan Melcher,Fiona Errington‐Mais,Gordon Cook	7
9	Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes 2013 ·Molecular Immunology ·Jehan J. El‐Jawhari,Yasser M. El‐Sherbiny,Gina B. Scott,Ruth Morgan,Robin Prestwich,(unknown),G. Eric Blair,Tomoyuki Tanaka,Terence H. Rabbitts,Josephine Meade,Graham P. Cook	44
10	Tumour Cell Generation of Inducible Regulatory T-Cells in Multiple Myeloma Is Contact-Dependent and Antigen-Presenting Cell-Independent 2012 ·PLoS ONE ·Sylvia Feyler,Gina B. Scott,Christopher Parrish,Sarah Jarmin,Paul Evans,(unknown),(unknown),Peter J. Selby,Gordon Cook	63
11	Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients 2011 ·BMC Medical Genetics ·Boling Qiao,Gina B. Scott,Faye Elliott,Laurence Vaslin,Johanne Bentley,Janet Hall,D. Timothy Bishop,Margaret A. Knowles,Anne E. Kiltie	3
12	In vitro functional effects of XPC gene rare variants from bladder cancer patients 2011 ·Carcinogenesis ·Boling Qiao,(unknown),Gina B. Scott,Sei Chung Sak,Philip Chambers,Faye Elliott,Mark Teo,Johanne Bentley,Michael Churchman,Janet Hall,Claire Taylor,D. Timothy Bishop,Margaret A. Knowles,Anne E. Kiltie	8
13	Detecting variable (V), diversity (D) and joining (J) gene segment recombination using a two-colour fluorescence system 2010 ·Mobile DNA ·Gina B. Scott,Erika A. de Wynter,Graham P. Cook	3
14	UCH‐L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease 2004 ·Journal of Neurochemistry ·H.C. Ardley,Gina B. Scott,Stephen A. Rose,(unknown),Philip A. Robinson	93
15	Inhibition of Proteasomal Activity Causes Inclusion Formation in Neuronal and Non-Neuronal Cells Overexpressing Parkin 2003 ·Molecular Biology of the Cell ·H.C. Ardley,Gina B. Scott,Stephen A. Rose,(unknown),Alexander F. Markham,Philip A. Robinson	98
16	Human homologue of ariadne promotes the ubiquitylation of translation initiation factor 4E homologous protein, 4EHP 2003 ·FEBS Letters ·(unknown),H.C. Ardley,Gina B. Scott,Stephen A. Rose,Alexander F. Markham,Philip A. Robinson	41
17	The yeast p53 functional assay: a new tool for molecular epidemiology. Hopes and facts 2000 ·Mutation Research/Reviews in Mutation Research ·Gilberto Fronza,Alberto Inga,Paola Monti,Gina B. Scott,Paola Campomenosi,Paola Menichini,Laura Ottaggio,Silvia Viaggi,Philip A. Burns,Barry Gold,Angelo Abbondandolo	24
18	Hot spot mutations in keratin 2e suggest a correlation between genotype and phenotype in patients with ichthyosis bullosa of Siemens 2000 ·Experimental Dermatology ·Yasushi Suga,Meral J. Arin,Gina B. Scott,Lowell A. Goldsmith,(unknown),Lynn A. Baden,Howard P. Baden,(unknown)	6
19	5-Methylcytosine at HpaII sites in p53 is not hypermutable after UVC irradiation 1999 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Paola Monti,Alberto Inga,Gina B. Scott,(unknown),Paola Campomenosi,Paola Menichini,Laura Ottaggio,Silvia Viaggi,Angelo Abbondandolo,Philip A. Burns,Gilberto Fronza	7
20	Relationship between DNA Methylation and Mutational Patterns Induced by a Sequence Selective Minor Groove Methylating Agent 1999 ·Journal of Biological Chemistry ·Jack Kelly,Alberto Inga,(unknown),Prasad Dande,(unknown),Paola Monti,(unknown),Philip A. Burns,Gina B. Scott,Angelo Abbondandolo,Barry Gold,Gilberto Fronza	37

About Gina B. Scott

Gina B. Scott is a scholar working on Immunology, Oncology and Hematology, having authored 27 papers that have together received 684 indexed citations. Recurring topics across this work include Virus-based gene therapy research (7 papers), CAR-T cell therapy research (7 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Oncology (238 citations), Immunology (159 citations) and Hematology (76 citations). Gina B. Scott has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Stephen A. Rose, H.C. Ardley, Philip A. Robinson, Alexander F. Markham, Philip A. Robinson, Christopher Parrish, Gordon Cook, Stephen G. Oliver, Alan Melcher and Colin P. Smith. Their work appears in journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact